News Releases

Apr 30, 2020
Lyra Therapeutics Announces Pricing of Initial Public Offering
WATERTOWN, Mass. --(BUSINESS WIRE)--Apr. 30, 2020-- Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced the pricing of its initial public offering of 3,500,000 shares of common stock at a public offering price of $16.00 per share, before deducting underwriting discounts and commissions.
Additional Formats
Jan 29, 2020
Lyra Therapeutics Completes $30 Million Series C Financing
Proceeds to advance company’s lead product candidates for the treatment of chronic rhinosinusitis Watertown, MA  – January 29, 2020 – Lyra Therapeutics, Inc., a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for
Additional Formats
Displaying 1 - 10 of 11
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top